Progression Free Survival below 12 Months Following Stem Cell Transplant Is a Hallmark of High-Risk Myeloma Which Is Associated with Inferior Overall Survival — Data from the Ukmrc Myeloma XI Trial
暂无分享,去创建一个
G. Morgan | W. Gregory | M. Drayson | M. Jenner | F. Davies | G. Cook | D. Cairns | M. Kaiser | R. Owen | M. Garg | C. Pawlyn | J. Lindsay | K. Karunanithi | John R. Jones | A. Hockaday | Andrea Paterson | G. Jackson | B. Kishore | C. Williams | A. Striha | C. Bygrave | N. Russel